Authors

M. Damodharan

M. Damodharan (CDO), PhD, is chief quality officer at Sai Life Sciences. He possesses more than 30 years of pharmaceutical industry experience. His vision to build future AI ready pharma organization, he is envisioned to apply AI and ML to improve pharmaceutical quality and productivity, leading impactful implementations such as manufacturing failure prediction models, and AI-driven retro synthesis for discovery.

Joseph Zeleznik is Technical Director, North America for IMCD US and is also a member of IPEC-Americas’ Executive Committee, currently serving as Immediate Past Chair.

Corporate Regulatory Affairs, ROQUETTE AMERICAS, INC.
Priscilla has over 35 years’ experience in Regulatory Affairs and Quality for excipients, food additives and ingredients for personal care products.She is currently President of the IPEC Federation and the Vice Chair of Science and Regulatory Policy for IPEC-Americas and is also a past Chair of the organization.

Katherine Ulman is the owner and Primary for KLU Consulting, LLC.She retired from Dow Corning Corporation after more than 40 years of employment.While at Dow Corning, she held positions as a global regulatory compliance manager for their Healthcare business as well as regulatory manager of the Dow Corning Healthcare Industries Materials Site.